The efficacy of intradermal hyaluronic acid filler as a skin quality booster: A prospective, single-center, single-arm pilot study

被引:0
|
作者
Lee, Joo Hee [1 ,2 ]
Kim, Jemin [3 ,4 ]
Lee, Yun Na [1 ,2 ]
Choi, Sooyeon [1 ,2 ]
Lee, Young In [1 ,2 ,3 ]
Suk, Jangmi [5 ]
Lee, Ju Hee [1 ,2 ,3 ,6 ,7 ]
机构
[1] Yonsei Univ, Dept Dermatol, Coll Med, Severance Hosp, Seoul, South Korea
[2] Yonsei Univ, Severance Hosp, Cutaneous Biol Res Inst, Coll Med, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Yonsei Canc Hosp, Scar Laser & Plast Surg Ctr, Seoul, South Korea
[4] Yonsei Univ, Coll Med, Yongin Severance Hosp, Dept Dermatol, Gyeonggi Do, South Korea
[5] Global Med Res Ctr, Seoul, South Korea
[6] Yonsei Univ, Coll Med, Dept Dermatol, 50-1 Yonsei Ro, Seoul 03722, South Korea
[7] Yonsei Univ, Cutaneous Biol Res Inst, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
关键词
filler; hyaluronic acid; skin aging; NONANIMAL ORIGIN; GEL; FACE;
D O I
10.1111/jocd.15944
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BackgroundThe use of "skin boosters" comprised of hyaluronic acid (HA)-based fillers to improve skin quality has gained popularity recently, especially in individuals interested in skin rejuvenation.AimThis study aimed to evaluate the efficacy and safety of intradermal micropuncture injections of HA-based gel filler combined with lidocaine (BYRYZN & REG; SKINBOOSTER HA, ACROSS Co., Ltd., Gangwon-do, Korea).Patients/MethodsA prospective, single-arm, open-label pilot study was conducted with study subjects who were aged between 30 and 60 years old and exhibited evidence of skin aging, such as wrinkles and loss of elasticity. They received three injections at 2-week intervals and were followed up for a total of 12 weeks.ResultsTwenty subjects with a mean age of 54.1 years were included. The mean Lemperle wrinkle scale demonstrated a 40% decrease from 2.60 & PLUSMN; 0.60 at baseline to 1.55 & PLUSMN; 0.51 at week 8. The improvement rate was maintained at about 33% until week 12. The average maximum height of the wrinkle (Rz, & mu;m), average skin roughness (Ra, & mu;m), skin elasticity (R2, AU), facial curved length (mm), skin pore size (mm2), skin hydration (AU), TEWL (g/hm2), and skin glossiness (gloss value, AU) exhibited statistically significant improvements over time compared with the baseline measurements. No serious adverse effects or persistent adverse effects were reported, except for a transient subcutaneous nodule in one subject.ConclusionsThis study demonstrates that multiple microinjections of HA-based gel filler for facial skin aging are safe and effective in improving facial skin quality.
引用
收藏
页码:409 / 416
页数:8
相关论文
共 50 条
  • [41] Efficacy and safety of low-dose cyclophosphamide combined with lenvatinib, pembrolizumab and TACE for unresectable hepatocellular carcinoma: A single-center, prospective, single-arm clinical trial
    Ren, Yupeng
    Li, Yuxuan
    Cao, Mingbo
    Tang, Yongchang
    Yuan, Feng
    Yang, Gaoyuan
    He, Zhiwei
    Shi, Zheng
    Su, Xiaorui
    Yao, Zhicheng
    Deng, Meihai
    CHINESE JOURNAL OF CANCER RESEARCH, 2024, 36 (02)
  • [42] Magnetic resonance-guided focused ultrasound for essential tremor: a prospective, single center, single-arm study
    Zong, Rui
    Li, Xuemei
    Yin, Chunyu
    He, Jianfeng
    Zhang, Dekang
    Bian, Xiangbing
    Huang, Lichao
    Zhou, Jiayou
    Ling, Zhipei
    Ma, Lin
    Lou, Xin
    Pan, Longsheng
    Yu, Xinguang
    NEURAL REGENERATION RESEARCH, 2024, 19 (09) : 2075 - 2080
  • [43] Efficacy of Omalizumab in chronic Urticaria - a prospective, single-center, Observational Study
    Traidl, S.
    Wedi, B.
    ALLERGOLOGIE, 2023, 46 (02) : 139 - 139
  • [44] TOCILIZUMAB MONO-THERAPY FOR POLYMYALGIA RHEUMATICA ∼ A SINGLE-CENTER, OPEN, SINGLE-ARM TRIAL
    Chino, K.
    Shibata, A.
    Okuyama, A.
    Kondo, T.
    Kikuchi, J.
    Sakai, R.
    Takei, H.
    Amano, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 400 - 400
  • [45] A single-center, prospective study on the efficacy of the of microfocused ultrasound for the noninvasive treatment of skin wrinkles above the elbow
    Rokhsar, Cameron
    Schnebelen, Wendy
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB21 - AB21
  • [46] Anlotinib in patients with recurrent platinum-resistant or refractory ovarian carcinoma: A prospective, single-arm, single-center, phase II clinical study.
    Wang, Huaying
    Shen, Wenbin
    Shan, Boer
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [47] Anlotinib plus chemotherapy as first-line treatment for advanced ovarian cancer: a prospective, single-arm, single-center, phase II clinical study
    Liu, Dechun
    Yan, Tao
    Zhang, Qian
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S89 - S90
  • [48] Robot-Assisted Radical Prostatectomy Using the KangDuo Surgical Robot-01 System: A Prospective, Single-Center, Single-Arm Clinical Study
    Kulis, Tomislav
    JOURNAL OF UROLOGY, 2022, 208 (01): : 127 - 127
  • [49] Efficacy and Safety Analysis of Transarterial Chemoembolization Plus Donafenib With or Without Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma: A Prospective, Single-Arm, Single-Center, Phase II Clinical Study
    Li, Jinpeng
    Li, Yan
    Song, Jinlong
    Zhao, Lujun
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 1207 - 1219
  • [50] A single-center, single-arm, prospective, open-label trial to evaluate the efficacy and safety of percutaneous sclerotherapy with polidocanol for painful venous malformations (SCIRO-2001): study protocol
    Uka, Mayu
    Sakurai, Jun
    Matsui, Yusuke
    Iguchi, Toshihiro
    Tomita, Koji
    Umakoshi, Noriyuki
    Munetomo, Kazuaki
    Mitsuhashi, Toshiharu
    Gobara, Hideo
    Hiraki, Takao
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2022, 84 (04): : 746 - 751